Zishaan Rauf · Research & Introductions

The Remediation Runway

What a 15-day response deadline actually buys a device maker — and the multi-year, six-figure-plus process that starts after it's filed.

TL;DR
  • A warning letter requires a written response within 15 working days — but that response is the easy part of the engagement, not the expensive one.
  • FDA's own published closeout data puts full resolution at 18–36 months from letter to close, not the few weeks most companies internally budget for.
  • Remediation — CAPA rebuild, documentation retrofit, retraining, reinspection prep — routinely runs past $250,000, and that figure is before any escalation.
  • CAPA failures are cited in over 60% of warning letters, which means most "warning letter remediation" is really a CAPA-system rebuild wearing a compliance-response costume.
  • Escalation past a warning letter to a consent decree moves the cost band from hundreds of thousands to $100M–$1B in remediation and lost production — the real reason speed and quality in the first 15 days compound over the following two years.

01What the 15-day response actually buys you

The clock on a warning letter starts immediately: a written response is expected within 15 working days, typically landing in the 2–4 week range in practice. That response is real and it matters — but it's a compliance document, not a fix. It buys time and signals intent. It does not rebuild a CAPA system, retrain a quality team, or get a facility through a reinspection.

02The real timeline: 18–36 months, not weeks

Based on FDA's own published closeout data, full resolution of a warning letter — from issuance to close — averages 18 to 36 months. Most internal teams plan around the 15-day response deadline as if it were the finish line. It's closer to the starting gun. A company that treats "we responded" as "we're done" is budgeting for roughly 5% of the actual timeline.

03Worked scenario — the CAPA-cited device maker

Setup: a device manufacturer receives a warning letter citing CAPA deficiencies — the single most common citation category, appearing in over 60% of warning letters. The 15-day written response goes out on time, drafted with outside help, addressing the cited findings on paper.

What doesn't happen in those 15 days: the underlying CAPA system doesn't get rebuilt, the documentation gap doesn't close, and the staff who generated the original findings aren't yet retrained. That work — the actual remediation — runs 18 to 36 months and, per industry cost reporting, more than $250,000 in direct spend before the company even reaches a reinspection.

The gap between "we responded" and "we're remediated" is where most manufacturers underestimate the engagement — and it's exactly where the wrong kind of consultant gets hired: someone who can write a compliant letter but has never taken a CAPA system through an actual reinspection.

04Why CAPA is the whole ballgame

CAPA violations are the leading cause of warning letters, present in more than 60% of enforcement actions. That single statistic reframes the entire problem: this isn't primarily a documentation exercise or a communications exercise. It's a systems-rebuild exercise, and systems don't get rebuilt in 15 days by anyone.

What a sharp device maker locks down now

  1. Don't let the 15-day response deadline set your internal remediation timeline expectation. It's the floor, not the finish line.
  2. Budget CAPA remediation at $250,000+ from day one, as a planned line item, not a contingency reserve.
  3. Audit your CAPA system before an inspection, not after a citation — it's the leading cause of warning letters for a reason.
  4. Bring in an operator who has taken a CAPA system through reinspection, not just written a compliant response letter. The two skills diverge sharply after day 15.
  5. Plan toward the 18–36 month resolution window explicitly. Treat anything faster as genuine outperformance, not the baseline case.

Sources referenced: FDA.gov warning letter database and published closeout data; industry FDA warning letter cost and consequence studies; FDA enforcement trend analysis, 2026.

Where Maitex fits

Maitex connects flagged device manufacturers with operators who've actually taken a CAPA system through reinspection — not consultants who stop at the 15-day response letter. The vetting bar is simple: has this operator closed out a warning letter, or just responded to one. That distinction is invisible on a website or a pitch deck; it only shows up in a track record.

Maitex has routed qualified introductions across adjacent regulated-manufacturing lanes, including nanofiber technology suppliers into pharma and medical device manufacturers — the same standard of operator vetting applies here.

Get in touch

zishaan@maitexai.com

linkedin.com/in/zishaanrauf